Early Tumor Marker Decrease To Predict The Efficacy Of Combination Therapy With Lenvatinib Plus Anti-Pd-1 Antibodies In Unresectable Hepatocellular Carcinoma (Uhcc).
JOURNAL OF CLINICAL ONCOLOGY(2021)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要